Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy are among the changes put forth by KDIGO.

Basing referral of patients with chronic kidney disease (CKD) to nephrologists on 2-year kidney failure risk exceeding 1% would catch those at higher risk without increasing referral volumes ...

A high-risk cohort of beneficiaries with chronic kidney disease (CKD) stage 3 have a profile similar to patients with CKD stages 4 and 5, indicating potential benefit of earlier nephrology ...

Primary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.

Guidelines for referral Referral of all patients with CKD would overwhelm renal services and is not necessary – criteria for referral are shown in the table. National UK guidelines for identification, ...

These guidelines describe key aspects of the management of chronic kidney disease to facilitate shared care for these patients by general practitioners and specialists, including internists, ...

Even women meeting objective criteria for CKD and nephrology referral were disadvantaged, according to investigators. Although chronic kidney disease (CKD) care has improved over time, women are ...

Boulware and her colleagues say early detection of CKD is especially critical given that previous studies indicate that, for many high-risk patients, the progression of kidney disease can be ...

Updated chronic kidney disease guidelines recommended including cystatin C with creatinine to estimate glomerular filtration rate. Point-of-care-testing for creatinine and urine albumin ...